Table of Content

1. PREFACE
1.1. Introduction
1.2. Key Market Insights
1.3. Scope of the Report
1.4. Research Methodology
1.5. Frequently Asked Questions
1.6. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION
3.1. Chapter Overview
3.2. Overview of Bioreactors
3.3. Components of a Bioreactor
3.4. Types of Bioreactors
3.4.1. Classification based on Type of Bioprocess
3.4.2. Classification based on Mode of Action
3.5. Applications of Bioreactors
3.6. Future Perspectives

4. FERMENTER AND BIOREACTOR MANUFACTURERS: MARKET LANDSCAPE
4.1. Chapter Overview
4.2. Fermenter and Bioreactor Manufacturers: Overall Market Landscape
4.2.1. Analysis by Year of Establishment
4.2.2. Analysis by Company Size
4.2.3. Analysis by Region of Headquarters
4.2.4. Analysis by Location of Headquarters
4.2.5. Analysis by Year of Establishment and Region of Headquarters
4.2.6. Analysis by Company Size and Region of Headquarters
4.2.7. Analysis by Year of Establishment, Company Size and Region of Headquarters
4.2.8. Analysis by Geographical Reach
4.2.9. Analysis by Region of Headquarters and Geographical Reach
4.2.10. Analysis by Type of Product
4.2.11. Analysis by Capacity
4.2.12. Analysis by Scale of Operation
4.2.13. Analysis by Scalability
4.2.14. Analysis by Type of Bioprocess
4.2.15. Analysis by Type of Cell Culture
4.2.16. Analysis by Mode of Operation
4.2.17. Analysis by Type of End-user
5. COMPANY COMPETITIVENESS ANALYSIS
5.1. Chapter Overview
5.2. Assumptions / Key Parameters
5.3. Methodology
5.4. Company Competitiveness Analysis: Small Companies
5.4.1. Company Competitiveness Analysis: Small Companies based in North America
5.4.2. Company Competitiveness Analysis: Small Companies based in Europe
5.4.3. Company Competitiveness Analysis: Small Companies based in Asia-Pacific and Rest of the World
5.5. Company Competitiveness Analysis: Mid-sized Companies
5.5.1. Company Competitiveness Analysis: Mid-sized Companies based in North America
5.5.2. Company Competitiveness Analysis: Mid-sized Companies based in Europe
5.5.3. Company Competitiveness Analysis: Mid-sized Companies based in Asia-Pacific and Rest of the World
5.6. Company Competitiveness Analysis: Large and Very Large Companies


6. COMPANY PROFILES
6.1. Chapter Overview
6.2. Applikon Biotechnology (acquired by Getinge)
6.2.1. Company Overview
6.2.2. Product Portfolio
6.2.3. Recent Developments and Future Outlook
6.3. Bionet
6.3.1. Company Overview
6.3.2. Product Portfolio
6.3.3. Recent Developments and Future Outlook
6.4. Cytiva
6.4.1. Company Overview
6.4.2. Financial Information
6.4.3. Product Portfolio
6.4.4. Recent Developments and Future Outlook
6.5. Eppendorf
6.5.1. Company Overview
6.5.2. Financial Information
6.5.3. Product Portfolio
6.5.4. Recent Developments and Future Outlook
6.6. Merck
6.6.1. Company Overview
6.6.2. Financial Information
6.6.3. Product Portfolio
6.6.4. Recent Developments and Future Outlook
6.7. Ollital Technology
6.7.1. Company Overview
6.7.2. Product Portfolio
6.7.3. Recent Developments and Future Outlook
6.8. Parr Instrument Company
6.8.1. Company Overview
6.8.2. Product Portfolio
6.8.3. Recent Developments and Future Outlook
6.9. Sartorius
6.9.1. Company Overview
6.9.2. Financial Information
6.9.3. Product Portfolio
6.9.4. Recent Developments and Future Outlook
6.10. Shanghai Bailun Biological Technology
6.10.1. Company Overview
6.10.2. Product Portfolio
6.10.3. Recent Developments and Future Outlook
6.11. Solaris Biotech (acquired by Donaldson Company)
6.11.1. Company Overview
6.11.2. Product Portfolio
6.11.3. Recent Developments and Future Outlook
6.12. Solida Biotech
6.12.1. Company Overview
6.12.2. Product Portfolio
6.12.3. Recent Developments and Future Outlook
6.13. Zhengzhou Laboao Instrument Equipment (LABAO)
6.13.1. Company Overview
6.13.2. Product Portfolio
6.13.3. Recent Developments and Future Outlook

7. CAPACITY ANALYSIS
7.1. Chapter Overview
7.2. Key Assumptions and Methodology
7.2.1 Bioreactors and Fermenters: Global Installed Capacity of Biologics
7.2.1.1. Analysis by Fabrication Material
7.2.1.2. Analysis by Source of Cell Culture
7.2.1.3. Analysis by Reactor Volume
7.2.1.4. Analysis by Type of Manufacturer
7.2.1.5. Analysis by Key Geographical Regions
7.3. Concluding Remarks

8. CASE STUDY: BIOPROCESS CONTROLLERS AND AUTOMATION SYSTEMS
8.1. Chapter Overview
8.2. Bioprocess Control Software: Overall Market Landscape
8.2.1. Analysis by Scale of Operation
8.2.2. Analysis by Key Features
8.2.3. Analysis by Compatibility with System
8.2.4. Analysis by Type of Process Controlled
8.3. Bioprocess Control Software Developers: Overall Market Landscape
8.3.1. Analysis by Year of Establishment
8.3.2. Analysis by Company Size
8.3.3. Analysis by Location of Headquarters
8.4. Upstream Controllers: Overall Market Landscape
8.4.1. Analysis by Scale of Operation
8.4.2. Analysis by Key Features
8.4.3. Analysis by Compatibility with Bioreactor System
8.4.4. Analysis by Type of Bioprocess
8.4.5. Analysis by Type of Process Controlled
8.5. Upstream Controller Developers: Overall Market Landscape
8.5.1. Analysis by Year of Establishment
8.5.2. Analysis by Company Size
8.5.3. Analysis by Location of Headquarters
8.6. Downstream Controller Systems: Overall Market Landscape
8.6.1. Analysis by Scale of Operation
8.6.2. Analysis by Key Features
8.6.3. Analysis by Type of System
8.6.4. Analysis by Type of Bioprocess
8.6.5. Analysis by Application Area
8.7. Downstream Controller System Developers: Overall Market Landscape
8.7.1. Analysis by Year of Establishment
8.7.2. Analysis by Company Size
8.7.3. Analysis by Location of Headquarters

9. MARKET FORECAST
9.1. Chapter Overview
9.2. Key Assumptions and Forecast Methodology
9.3. Global Fermenters and Bioreactors Market, 2023-2035
9.3.1. Global Fermenters and Bioreactors Market, 2023-2035: Distribution by Type of Product
9.3.1.1. Global Bioreactors Market, 2023-2035
9.3.1.2. Global Fermenters Market, 2023-2035
9.3.2. Global Fermenters and Bioreactors Market, 2023-2035: Distribution by Fabrication Material
9.3.2.1. Global Glass Fermenters and Bioreactors Market, 2023-2035
9.3.2.2. Global Stainless Steel Fermenters and Bioreactors Market, 2023-2035
9.3.2.3. Global Single Use Fermenters and Bioreactors Market, 2023-2035
9.3.3. Global Fermenters and Bioreactors Market, 2023-2035: Distribution by Type of Bioprocess
9.3.3.1. Global Fermenters and Bioreactors Market for Batch and Fed-batch Process, 2023-2035
9.3.3.2. Global Fermenters and Bioreactors Market for Continuous Process, 2023-2035
9.3.4. Global Fermenters and Bioreactors Market, 2023-2035: Distribution by Type of Biologic
9.3.4.1. Global Fermenters and Bioreactors Market for Antibodies, 2023-2035
9.3.4.2. Global Fermenters and Bioreactors Market for Vaccines, 2023-2035
9.3.4.3. Global Fermenters and Bioreactors Market for Cell Therapies, 2023-2035
9.3.4.4. Global Fermenters and Bioreactors Market for Other Biologics, 2023-2035
9.3.5. Global Fermenters and Bioreactors Market, 2023-2035: Distribution by Key Geographical Regions
9.3.5.1. Global Fermenters and Bioreactors Market in North America, 2023-2035
9.3.5.2. Global Fermenters and Bioreactors Market in Europe, 2023-2035
9.3.5.3. Global Fermenters and Bioreactors Market in Asia-Pacific, 2023-2035
9.3.5.4. Global Fermenters and Bioreactors Market in Middle East and North Africa, 2023-2035
9.3.5.5. Global Fermenters and Bioreactors Market in Latin America, 2023-2035
10. EXECUTIVE INSIGHTS
11. CONCLUDING REMARKS
12. APPENDIX 1: TABULATED DATA
13. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS